Blue Cross and Blue Shield of Texas policy
Gene Therapy for Aromatic L-amino Acid Decarboxylase Deficiency
Gene Therapy for Aromatic L-amino Acid Decarboxylase Deficiency is a public Blue Cross and Blue Shield of Texas policy (policy RX501.178, effective Nov 15, 2025). It lists 3 CPT or HCPCS codes. Not a coverage decision; the payer's own document governs.
View the original policy (PDF) ↗
Check eligibility for free
No account required. Sign a BAA to see plan details, coordination of benefits and more
- Policy number
- RX501.178
- Effective
- Nov 15, 2025
- Line of business
- Commercial, Medicaid
- Source
- medicalpolicy.hcsc.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Open official prior authorization lists to check the member’s product.
| Code | Other Blue Cross and Blue Shield of Texas policies |
|---|---|
| C9399 | Policies naming C9399 |
| J3490 | Policies naming J3490 |
| J3590 | Policies naming J3590 |
All Blue Cross and Blue Shield of Texas policies · Blue Cross and Blue Shield of Texas prior authorization CPT list